Report: Schumer, Gillibrand want morcellators off the market

August 19, 2014 by Brad Perriello

Sens. Chuck Schumer and Kristen Gillibrand plan to ask the FDA to push medical device companies to pull power morcellators off the U.S. market, after the hysterectomy devices were implicated in spreading uterine cancers.

Report: Schumer, Gillibrand want morcellators off the market

The U.S. Senate delegation from New York want to see power morcellators, which have been linked to the spread of undiagnosed uterine cancer, pulled from the U.S. market, the Wall Street Journal reported last night.

The devices are used during laparoscopic surgeries to shred and remove supposedly benign uterine fibroids, but in patients who have an undetected type of uterine cancer the morcellators can spread the cancerous cells.

Sign up to get our free newsletters delivered straight to your inbox

Last month Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery voluntarily asked for the return of its laparoscopic power morcellators used in fibroid surgeries, a few months after it suspended sales of the devices on FDA warnings of the cancer risk. Earlier in July an FDA panel failed to come to a clear decision on the cancer risk from laparoscopic power morcellators, despite outraged testimony from dozens of attendees.

Comments